News
MarketBeat Week in Review – 6/19 - 6/23
Markets pulled back this week, but the reason for the price action may not be clear. Some investors will point to remarks from Fed chair Jerome Powell who continued his “hawkish pause” language in
EQS-News: China Merchants Land Redeems RMB1,900 Million Bonds Maintains Strong Financial Position
KB Home: Building on Strong Foundations During Volatile Times
KB Home (NYSE: KBH) is a significant player in the U.S. residential construction industry and part of the broader real estate sector. The company mainly caters to first-time and move-up
KB Home’s Stock Price Can Move Higher, Here’s Why
KB Home’s (NYSE: KBH) stock price can increase in 2024 despite struggles with traction following the Q1 release. The company is firing on all cylinders and driving value for shareholders with no
4 reasons to buy the dip in KB Home
KB Home (NYSE: KBH) is no high-yielding or hyper-growth stock, but there is more to capital returns and shareholder value than that. Despite numerous economic headwinds and widespread housing
KB Home Price Weakness is a Signal to Buy this Cash Machine
KB Home (NYSE: KBH) is selling off on a narrowing margin and FOMC hawkishness, but don't be fooled. The sell-off has shares down 16% from their highs, and they may go lower, but this is good news
These 3 Homebuilders Have Robust Cash Flow To Drive Their Rallies
This year, it has been easy to be a contrarian about the homebuilders (NYSEARCA: XHB). The stocks are rallying on strength, driven by a rapidly diminishing backlog with an outlook that includes a
KB Home Hits Peak: Pullback Imminent
KB Home (NYSE: KBH) reported a solid quarter and raised guidance, but the news may not be enough to keep the market moving higher. While better than expected, the results and guidance point to a
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
Despite rising mortgage rates and a slightly cooling housing market, homebuilding stocks like Lennar (NYSE: LEN) and KB Homes (NYSE: KBH) are ripping higher and outperforming the S&P 500.
The
3 Late-Season Earnings Plays for Mid-Cap Traders
As June rolls around, amusement parks and beachside cabanas are getting worked into the budgets of vacation-hungry Americans. For U.S. stock traders, summer’s kickoff coincides with the conclusion
Evaxion gibt ermutigende erste klinische Daten der Phase II zu seinem personalisierten Krebsimpfstoff EVX-01 bekannt
- Erste Phase-II-Daten von EVX-01 bestätigen die guten Ergebnisse der Phase I
- Nach der Behandlung mit EVX-01 wurde bei einem Patienten mit metastasierendem Melanom und anfänglichem Fortschreiten der
Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
- An innovative covalent platform for precision targeting of disease-causing proteins
- Seed financing led by RA Capital Management, Droia Ventures, and Novartis Venture
KB Home Constructs Bullish Price Action As Wider Industry Thrives
Key Points
- High interest rates are keeping homeowners in place, boosting homebuilders’ stocks.
- KB Home, a Los Angeles-based midcap, shows potential for further gains as it consolidates in a
